UHN launches study to explore how Apple Watch can help with early identification of worsening heart failure
Renowned Canadian cardiologist Dr. Heather Ross, of the Ted Rogers Centre for Heart Research at the Peter Munk Cardiac Centre, UHN, will lead a study to learn how remote monitoring through Apple Watch can drive better clinical outcomes for heart failure patients.
Newswise Toronto (February 18, 2021) – As part of the University Health Network, renowned cardiologist Dr. Heather Ross has launched a new clinical study, in collaboration with Apple to test if remote monitoring with Apple Watch can help with early identification of worsening heart failure.
What comes next: UHN’s continued effort in defeating COVID-19
Post-vaccine, there are still a lot of unknowns when it comes to the virus’ long-term impacts By Joseph Cicerone
Created for
Dr. Bradly Wouters was present as one of Canada’s first COVID-19 vaccines was administered to a personal support worker at Toronto’s University Health Network (UHN) in December. A symbol of optimism, that historic day has affirmed the value of science and global cooperation amidst the pandemic. “I don’t think we can understate how incredible it is that the world collectively developed safe, effective vaccines in a period of 10 months,” says Dr. Wouters, UHN’s Executive Vice President of Science and Research. After months of collective distress, Canadians are beginning to anticipate an end to what many have described as the greatest challenge of our lifetime.
Credit: Courtesy UHN
TORONTO (February 5, 2021) - A clinical study led by Dr. Jordan Feld, a liver specialist at Toronto Centre for Liver Disease, University Health Network (UHN), showed an experimental antiviral drug can significantly speed up recovery for COVID-19 outpatients - patients who do not need to be hospitalized.
This could become an important intervention to treat infected patients and help curb community spread, while COVID-19 vaccines are rolled out this year. This treatment has large therapeutic potential, especially at this moment as we see aggressive variants of the virus spreading around the globe which are less sensitive to both vaccines and treatment with antibodies, says Dr. Feld, who is also Co-Director of the Schwartz Reisman Liver Research Centre and the R. Phelan Chair in Translational Liver Research at UHN.
TELUS launches newest Health for Good mobile clinic to support Toronto’s most marginalized citizens
TORONTO, Jan. 21, 2021 Today, TELUS announced the expansion of the company’s innovative
Health for Good program with Parkdale Queen West Community Health Centre (CHC) and University Health Network’s (UHN) Social Medicine Program. The Parkdale Queen West Mobile Health Clinic powered by TELUS Health, a specially-equipped clinic on wheels, will provide essential primary health and harm reduction services directly to underserved persons in neighbourhoods in the mid-west region of Toronto. In addition, the clinic will enable mobile COVID-19 testing and vaccination efforts at homeless sheltering sites, congregate housing for marginalized populations and in areas with high positivity rates.
NeonMind Biosciences Inc: NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials
NeonMind Biosciences Inc. (
CSE: NEON) (
NeonMind ) a company conducting research into the potentially therapeutic uses of compounds found in psychedelic mushrooms, is pleased to announce that it has added Frank Russo as an advisor and consultant to assist the Company in selecting or developing music playlists for its clinical trials or for use with treatments to support optimum mental health.
NeonMind Engages Music Expert Dr. Frank Russo
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7646/72039 img1a.jpg